Abstract

Background: The death of pancreatic islet β-cells (β-cells), which are the insulin-producing cells, promote the pathology in both Type 1 and Type 2 diabetes mellitus (DM) (T1DM and T2DM), and they are protected by autophagy which is one of the mechanisms of cell survival. Recently, that some advanced glycation end-products (AGEs), such as methylglyoxial-derived AGEs and Nε-carboxymethyllysine, induced the death of β-cells were revealed. In contrast, we had reported AGEs derived from glyceraldehyde (GA, the metabolism intermediate of glucose and fructose) are considered to be toxic AGEs (TAGE) due to their cytotoxicity and role in the pathogenesis of T2DM. More, serum levels of TAGE are elevated in patients with T1 and T2DM, where they exert cytotoxicity. Aim: We researched the cytotoxicity of intracellular and extracellular TAGE in β-cells and the possibility that intracellular TAGE were associated with autophagy. Methods: 1.4E7 cells (a human β-cell line) were treated with GA, and analyzed viability, quantity of TAGE, microtubule-associated protein 1 light chain 3 (LC3)-I, LC3-II, and p62. We also examined the viability of 1.4E7 cells treated with TAGE-modified bovine serum albumin, a model of TAGE in the blood. Results: Intracellular TAGE induced death of 1.4E7 cells, decrease of LC3-I, LC3-II, and p62. Extracellular TAGE didn’t show cytotoxicity in the physiological concentration. Conclusion: Intracellular TAGE induced death of β-cells more strongly than extracellular TAGE, and may suppress autophagy via reduction of LC3-I, LC3-II, and p62 to inhibit the degradation of them.

Highlights

  • Diabetes mellitus (DM) exists as type 1 (T1DM) and type 2 (T2DM)

  • Generation of intracellular toxic AGEs (TAGE), and light chain 3 (LC3)-I, LC3-II, and p62 protein levels in 1.4E7 cells treated with GA

  • Intracellular TAGE levels in 1.4E7 cells increased with GA in an approximately dose-dependent manner (Figure 1b)

Read more

Summary

Introduction

Diabetes mellitus (DM) exists as type 1 (T1DM) and type 2 (T2DM). The latter is a lifestyle-related disease (LSRD) and one of the greatest public health challenges in the world [1]. There is a system that protects β-cells against dysfunction and death such as autophagy in T2DM [4]. Advanced glycation end-products (AGEs), such as metylglyoxial-derived AGEs (MGOAGEs) and Nε -carboxymethyllysine (CML), have been reported to be generated/exist in β-cells, induce death and dysfunction of them, and they may be associated with the promotion of DM [6,7]. The death of pancreatic islet β-cells (β-cells), which are the insulin-producing cells, promote the pathology in both Type 1 and Type 2 diabetes mellitus (DM) (T1DM and T2DM), and they are protected by autophagy which is one of the mechanisms of cell survival. AGEs derived from glyceraldehyde (GA, the metabolism intermediate of glucose and fructose) are considered to be toxic AGEs (TAGE) due to their cytotoxicity and role in the pathogenesis of.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call